Israel Englander Vbi Vaccines Inc Transaction History

Millennium Management LLC

$207 Billion
Q2 2024

20 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2023 May 15, 2023	SELL	$0.29 - $0.64 $108,251 - $238,900	-373,282 Reduced 95.83%	16,229 $5,000
Q4 2022 Feb 14, 2023	SELL	$0.38 - $22.5 $277,485 - $16.4 Million	-730,224 Reduced 65.21%	389,511 $152,000
Q3 2022 Nov 14, 2022	SELL	$0.73 - $23.4 $482,542 - $15.5 Million	-661,017 Reduced 37.12%	1,119,735 $790,000
Q2 2022 Aug 15, 2022	BUY	$0.66 - $1.81 $798,199 - $2.19 Million	1,209,393 Added 211.67%	1,780,752 $1.44 Million
Q1 2022 May 16, 2022	SELL	$1.27 - $2.47 $1.49 Million - $2.89 Million	-1,170,139 Reduced 67.19%	571,359 $948,000
Q4 2021 Feb 14, 2022	BUY	$2.21 - $3.22 $1.18 Million - $1.73 Million	535,968 Added 44.46%	1,741,498 $4.08 Million
Q3 2021 Nov 15, 2021	BUY	$2.8 - $3.72 $1.33 Million - $1.77 Million	474,907 Added 65.0%	1,205,530 $3.75 Million
Q2 2021 Aug 16, 2021	BUY	$2.61 - $4.17 $1.03 Million - $1.64 Million	394,063 Added 117.09%	730,623 $2.45 Million
Q1 2021 May 17, 2021	BUY	$2.91 - $4.32 $979,389 - $1.45 Million	336,560 New	336,560 $1.05 Million
Q4 2020 Feb 16, 2021	SELL	$2.15 - $3.5 $4.05 Million - $6.59 Million	-1,883,290 Closed	0 $0
Q3 2020 Nov 16, 2020	BUY	$2.77 - $6.17 $3.85 Million - $8.58 Million	1,390,751 Added 282.36%	1,883,290 $5.39 Million
Q2 2020 Aug 14, 2020	BUY	$0.87 - $3.13 $428,508 - $1.54 Million	492,539 New	492,539 $1.53 Million
Q2 2019 Aug 14, 2019	SELL	$0.65 - $2.12 $509,389 - $1.66 Million	-783,676 Closed	0 $0
Q1 2019 May 14, 2019	BUY	$1.54 - $2.01 $41,037 - $53,562	26,648 Added 3.52%	783,676 $1.47 Million
Q4 2018 Feb 14, 2019	BUY	$1.22 - $2.41 $731,919 - $1.45 Million	599,934 Added 381.89%	757,028 $1.21 Million
Q3 2018 Nov 14, 2018	SELL	$1.75 - $2.93 $654,540 - $1.1 Million	-374,023 Reduced 70.42%	157,094 $380,000
Q2 2018 Aug 14, 2018	BUY	$2.75 - $3.85 $792,588 - $1.11 Million	288,214 Added 118.65%	531,117 $1.46 Million
Q1 2018 May 15, 2018	SELL	$3.5 - $4.47 $9,450 - $12,069	-2,700 Reduced 1.1%	242,903 $850,000
Q4 2017 Feb 14, 2018	BUY	$3.29 - $5.03 $388,904 - $594,586	118,208 Added 92.79%	245,603 $1.05 Million
Q3 2017 Nov 14, 2017	BUY	$3.15 - $4.01 $401,294 - $510,853	127,395	127,395 $490,000

Others Institutions Holding VBIV

# of Institutions

Shares Held

688K

Call Options Held

Put Options Held

Frontier Wealth Management LLC Kansas City, MO

602K
Shares

$12,036
0.01% of portfolio
ETF Managers Group, LLC Summit, NJ

85.7K
Shares

$1,714
0.0% of portfolio

View Full List

About VBI Vaccines Inc

Ticker VBIV
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 258,256,992
Market Cap $5.17M
Description
VBI Vaccines Inc., a biopharmaceutical company, develops and sells vaccines for the treatment of infectious diseases and immuno-oncology. The company offers Sci-B-Vac, a prophylactic hepatitis B (HBV) vaccine. It also engages in the development of VBI-2601 (BRII-179), an immunotherapeutic candidate for the treatment of chronic HBV infection. The...

More about VBIV

Track Israel Englander's Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Millennium Management LLC, based on Form 13F filings with the SEC.

News

Stay updated on Millennium Management LLC and Israel Englander with notifications on news.

Account